Elite Pharmaceuticals, Inc. (QB) Stock Price - ELTP

Best deals to access real time data!
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Elite Pharmaceuticals, Inc. (QB) ELTP Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 0.104 - - - 0.104 06:01:34
Bid Price Ask Price Spread Spread % News
0.0001 8 7.9999 100.00% - -
Last Trade Time Type Quantity Stock Price Currency
- - - USD

Elite Pharmaceuticals, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 82.32M 791.52M $ 3.81M - 21.60 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Elite Pharmaceuticals, Inc. (QB) News

Latest ELTP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ELTP Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.1060.110.09980.1031257k828k529k-0.002-1.89%
1 Month0.10520.110.09750.1042153k1M580k-0.0012-1.14%
3 Months0.09050.1450.0810.113592k5M1M0.013514.92%
6 Months0.09530.1450.0560.102792k5M888k0.00879.13%
1 Year0.150.24950.0560.130892k14M983k-0.046-30.67%
3 Years0.24350.4430.0560.220692k20M1M-0.1395-57.29%
5 Years0.0850.970.00010.266492k29M2M0.01922.35%

Elite Pharmaceuticals, Inc. (QB) Description

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company which is developing a pipeline of proprietary pharmacological abuse deterrent opioid products as well as niche generic products. Elite specializes in oral sustained and controlled release drug products which have high barriers to entry. Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddys Laboratories and Valeant Pharmaceuticals International. Elite currently has nine commercial products being sold, four products under review pending approval by the FDA, additional approved products pending manufacturing site transfer and the NDA filing for SequestOx. Elites lead pipeline products include abuse-deterrent opioids which utilize the Companys patented proprietary technology and a once-daily opioid. These products include sustained release oral formulations of opioids for the treatment of chronic pain. These formulations are intended to address two major limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential opioid abuse. Elite also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Elite operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale, NJ. Learn more at www.elitepharma.com.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.